Aprogen Medicines Inc. (007460.KS)
KRW 705.0
(2.03%)
KRW 705.0
(2.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -65.89 Billion KRW | -1.18% |
| 2022 | -76.14 Billion KRW | -918.41% |
| 2021 | -70.54 Billion KRW | -164.42% |
| 2020 | -20.34 Billion KRW | -77.77% |
| 2019 | 40.81 Billion KRW | 5523.91% |
| 2018 | 741.42 Million KRW | -118.4% |
| 2017 | 4.59 Billion KRW | -40.39% |
| 2016 | 7.38 Billion KRW | -20.14% |
| 2015 | 9.49 Billion KRW | -56.02% |
| 2014 | 20.99 Billion KRW | 60.08% |
| 2013 | 9.17 Billion KRW | -69.83% |
| 2012 | 43.92 Billion KRW | 302.13% |
| 2011 | -21.91 Billion KRW | -431.28% |
| 2010 | 7.14 Billion KRW | -70.5% |
| 2009 | 22.33 Billion KRW | -9.31% |
| 2008 | 24.72 Billion KRW | 49.59% |
| 2007 | 18.3 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -13.46 Billion KRW | 28.73% |
| 2024 Q1 | -13.32 Billion KRW | 43.91% |
| 2023 Q2 | -14.16 Billion KRW | -248.28% |
| 2023 Q1 | 9.55 Billion KRW | 176.15% |
| 2023 Q3 | 5.1 Billion KRW | 136.02% |
| 2023 FY | - KRW | -1.18% |
| 2023 Q4 | -24.26 Billion KRW | -575.68% |
| 2022 Q3 | -20.99 Billion KRW | -493.25% |
| 2022 FY | - KRW | -918.41% |
| 2022 Q1 | -1.81 Billion KRW | -64.03% |
| 2022 Q2 | -3.53 Billion KRW | -95.43% |
| 2022 Q4 | -12.54 Billion KRW | 40.25% |
| 2021 Q3 | -1.53 Billion KRW | 38.82% |
| 2021 Q4 | -1.1 Billion KRW | 28.16% |
| 2021 FY | - KRW | -164.42% |
| 2021 Q1 | -1.24 Billion KRW | -137.91% |
| 2021 Q2 | -2.51 Billion KRW | -101.39% |
| 2020 Q1 | 2.54 Billion KRW | -91.41% |
| 2020 Q2 | 1.55 Billion KRW | -38.98% |
| 2020 Q3 | 2.15 Billion KRW | 38.68% |
| 2020 Q4 | 3.29 Billion KRW | 52.91% |
| 2020 FY | - KRW | -77.77% |
| 2019 Q2 | 841.9 Million KRW | 224.12% |
| 2019 FY | - KRW | 5523.91% |
| 2019 Q1 | -678.28 Million KRW | 89.91% |
| 2019 Q4 | 29.6 Billion KRW | 2250.87% |
| 2019 Q3 | 1.25 Billion KRW | 49.59% |
| 2018 Q1 | 1.56 Billion KRW | 0.0% |
| 2018 Q4 | -6.72 Billion KRW | -390.05% |
| 2018 FY | - KRW | -118.4% |
| 2018 Q3 | 2.31 Billion KRW | -19.78% |
| 2018 Q2 | 2.88 Billion KRW | 84.2% |
| 2017 Q1 | 1.79 Billion KRW | -32.77% |
| 2017 Q3 | 791.63 Million KRW | -49.59% |
| 2017 FY | - KRW | -40.39% |
| 2017 Q2 | 1.57 Billion KRW | -12.44% |
| 2016 FY | - KRW | -20.14% |
| 2016 Q2 | 1.79 Billion KRW | -40.03% |
| 2016 Q1 | 2.98 Billion KRW | 449.27% |
| 2016 Q3 | 605.64 Million KRW | -66.2% |
| 2016 Q4 | 2.66 Billion KRW | 340.48% |
| 2015 FY | - KRW | -56.02% |
| 2015 Q4 | -855.45 Million KRW | -127.57% |
| 2015 Q3 | 3.1 Billion KRW | -12.36% |
| 2015 Q2 | 3.54 Billion KRW | 1.9% |
| 2015 Q1 | 3.47 Billion KRW | -34.82% |
| 2014 Q3 | 3.8 Billion KRW | 131.44% |
| 2014 Q2 | 1.64 Billion KRW | -77.19% |
| 2014 Q1 | 7.2 Billion KRW | 0.0% |
| 2014 FY | - KRW | 60.08% |
| 2014 Q4 | 5.33 Billion KRW | 40.13% |
| 2013 Q3 | 1.01 Billion KRW | 189.78% |
| 2013 Q1 | 5.43 Billion KRW | -85.12% |
| 2013 Q4 | - KRW | -100.0% |
| 2013 FY | - KRW | -69.83% |
| 2013 Q2 | -1.12 Billion KRW | -120.72% |
| 2012 FY | - KRW | 302.13% |
| 2012 Q1 | 4.59 Billion KRW | 0.0% |
| 2012 Q2 | 20.38 Billion KRW | 343.61% |
| 2012 Q3 | -18.06 Billion KRW | -188.62% |
| 2012 Q4 | 36.51 Billion KRW | 302.12% |
| 2011 Q4 | - KRW | -100.0% |
| 2011 FY | - KRW | -431.28% |
| 2011 Q1 | 4.68 Billion KRW | 0.0% |
| 2011 Q2 | 1.75 Billion KRW | -62.61% |
| 2011 Q3 | 1.02 Billion KRW | -41.4% |
| 2010 Q3 | 1.04 Billion KRW | -43.97% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q2 | 1.86 Billion KRW | -56.07% |
| 2010 Q1 | 4.23 Billion KRW | 0.0% |
| 2010 FY | - KRW | -70.5% |
| 2009 Q3 | 3.36 Billion KRW | -49.08% |
| 2009 Q4 | - KRW | -100.0% |
| 2009 Q2 | 6.61 Billion KRW | 80.68% |
| 2009 Q1 | 3.66 Billion KRW | 0.0% |
| 2009 FY | - KRW | -9.31% |
| 2008 Q1 | 5.91 Billion KRW | 0.0% |
| 2008 Q2 | 5.64 Billion KRW | -4.57% |
| 2008 Q3 | 4.16 Billion KRW | -26.2% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 FY | - KRW | 49.59% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q3 | 1.76 Billion KRW | -47.42% |
| 2007 Q4 | - KRW | -100.0% |
| 2007 Q2 | 3.34 Billion KRW | 9.26% |
| 2007 Q1 | 3.06 Billion KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hwacheon Machine Tool Co. Ltd | 18.16 Billion KRW | 462.797% |
| SIMPAC Inc. | 29.32 Billion KRW | 324.698% |
| Kyung Dong Navien Co., Ltd. | 163.18 Billion KRW | 140.384% |
| Korea Shipbuilding & Offshore Engineering Co., Ltd. | 753.13 Billion KRW | 108.75% |
| Korea Refractories Co., Ltd | -7.42 Billion KRW | -787.717% |
| Woojin I&S Co., Ltd. | -1.33 Billion KRW | -4822.098% |
| Hwacheon Machinery Co., Ltd. | 5.86 Billion KRW | 1224.344% |
| Hanshin Machinery Co., Ltd. | -1.36 Billion KRW | -4726.847% |
| STX Corporation | 5.42 Billion KRW | 1315.632% |
| Curo Co.,Ltd. | 22.19 Billion KRW | 396.929% |
| Hyundai Elevator Co., Ltd | 502.4 Billion KRW | 113.117% |
| Doosan Enerbility Co., Ltd. | 1567.61 Billion KRW | 104.204% |
| Woojin Plaimm Co., Ltd. | 17.37 Billion KRW | 479.261% |
| STX Heavy Industries Co., Ltd. | 20.62 Billion KRW | 419.585% |
| STX Engine Co.,Ltd. | 28.27 Billion KRW | 333.055% |
| HSD Engine Co., Ltd. | 26.26 Billion KRW | 350.855% |
| NK Co., Ltd. | 2.38 Billion KRW | 2865.423% |
| SNT Energy Co., Ltd. | 26.48 Billion KRW | 348.804% |
| CS Wind Corporation | 178 Billion KRW | 137.021% |
| Dynamic Design Co., LTD. | -21.95 Billion KRW | -200.141% |
| HD Hyundai Co., Ltd. | 3790.96 Billion KRW | 101.738% |
| Hyosung Heavy Industries Corporation | 345.44 Billion KRW | 119.077% |
| LG Energy Solution, Ltd. | 4286.08 Billion KRW | 101.538% |